42Stockpicking

CSTL

Castle Biosciences IncKøb· 76.3%· 23. maj 2026
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
—
EV/EBITDAi
—
P/Bi
1,4
16th %ile · 404p
P/Si
1,1
26th %ile · 356p
EV/Salesi
1,0
23rd %ile · 356p
Div yieldi
—

Kursudvikling

Kun 135 handelsdage i databasen. Viser al tilgængelig historik.

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026none
Prishistorik
0,3 år
Pris-dage
77
Årsregnskaber
9
Peers
0/0
Valuation
3/6
Fundamentals
8/8
Datovindue
2026-02-09 til 2026-05-29

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Mangler ca. 9,7 års prishistorik før ideal/full.
  • Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
  • Kør compute-multiples for manglende valuation metrics.

Seneste assessment

CSTL vurderet 2026-06-10

Score
41.7%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

33%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

68%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

18%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

56%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

52%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

68%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: P/E relative valuation needs both own multiple and peer median.

Insider activity

Net 90d (aktier)
-124.390
Net 90d (værdi)
-3.536.817 USD
Købere 90d
0
Cluster
—
DatoPersonRolleTypeAntalVærdiKilde
25.8.2026Oelschlager Kristen MChief Operating Officer▼ SALG-7.161-245.357 USDsec
24.8.2026Oelschlager Kristen MChief Operating Officer▼ SALG-12.218-411.588 USDsec
17.8.2026Juvenal Tobin WChief Commercial Officer▼ SALG-1.730-51.191 USDsec
14.8.2026MAETZOLD DEREK JPres. & Chief Exec. Officer◆ OPT.1.1002.629 USDsec
14.8.2026Stokes FrankChief Financial Officer▼ SALG-24.908-741.511 USDsec
14.8.2026MAETZOLD DEREK JPres. & Chief Exec. Officer▼ SALG-1.100-33.022 USDsec
5.8.2026MAETZOLD DEREK JPres. & Chief Exec. Officer▼ SALG-2.546-78.114 USDsec
5.8.2026MAETZOLD DEREK JPres. & Chief Exec. Officer◆ OPT.2.5466.085 USDsec
4.8.2026MAETZOLD DEREK JPres. & Chief Exec. Officer◆ OPT.20.35648.651 USDsec
4.8.2026MAETZOLD DEREK JPres. & Chief Exec. Officer▼ SALG-8.421-259.266 USDsec
3.8.2026Juvenal Tobin WChief Commercial Officer▼ SALG-1.730-48.873 USDsec
3.8.2026Oelschlager Kristen MChief Operating Officer▼ SALG-3.000-87.360 USDsec
3.8.2026MAETZOLD DEREK JPres. & Chief Exec. Officer◆ OPT.10.66425.487 USDsec
3.8.2026MAETZOLD DEREK JPres. & Chief Exec. Officer▼ SALG-10.664-323.684 USDsec
31.7.2026Juvenal Tobin WChief Commercial Officer▼ SALG-8.149-235.033 USDsec
31.7.2026MAETZOLD DEREK JPres. & Chief Exec. Officer▼ SALG-6.480-195.385 USDsec
31.7.2026MAETZOLD DEREK JPres. & Chief Exec. Officer◆ OPT.6.48015.487 USDsec
27.7.2026MAETZOLD DEREK JPres. & Chief Exec. Officer▼ SALG-5.982-144.346 USDsec
27.7.2026MAETZOLD DEREK JPres. & Chief Exec. Officer◆ OPT.6.21414.851 USDsec
14.7.2026MAETZOLD DEREK JPres. & Chief Exec. Officer▼ SALG-550-12.606 USDsec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q130.4.2026-0,49-0,49-0.3%-0.3%Inline
2025Q430.1.2026-0,08-0,26+69.1%+69.1%Beat
2025Q330.10.2025-0,02-0,51+96.1%+96.1%Beat
2025Q230.7.20250,15-0,50+130.0%+130.0%Beat